Literature DB >> 19758207

Influenza and autoimmunity.

Natasa Toplak1, Tadej Avcin.   

Abstract

Influenza infection can cause mild to severe illness and can even lead to death. The best way to prevent infection is vaccination against influenza. Complications of influenza infection are not only a consequence of acute infection but can also present as late autoimmune response. Influenza is not frequently implicated as a trigger for autoimmune diseases, but case reports of autoimmune adverse events have been published even following influenza vaccination. In this article we review published data on autoimmune diseases following influenza infection and vaccination. We also discuss immunity of influenza infection in connection to pathogenesis of autoimmune response and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758207     DOI: 10.1111/j.1749-6632.2009.04759.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence?

Authors:  Caroline Hofmann; Marc-Oliver Baur; Horst Schroten
Journal:  J Neurol       Date:  2010-09-30       Impact factor: 4.849

2.  Anti-Self Phosphatidylserine Antibodies Recognize Uninfected Erythrocytes Promoting Malarial Anemia.

Authors:  Cristina Fernandez-Arias; Juan Rivera-Correa; Julio Gallego-Delgado; Rachel Rudlaff; Clemente Fernandez; Camille Roussel; Anton Götz; Sandra Gonzalez; Akshaya Mohanty; Sanjib Mohanty; Samuel Wassmer; Pierre Buffet; Papa Alioune Ndour; Ana Rodriguez
Journal:  Cell Host Microbe       Date:  2016-02-10       Impact factor: 21.023

3.  HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages.

Authors:  M Anthony Moody; Nicole L Yates; Joshua D Amos; Mark S Drinker; Joshua A Eudailey; Thaddeus C Gurley; Dawn J Marshall; John F Whitesides; Xi Chen; Andrew Foulger; Jae-Sung Yu; Ruijun Zhang; R Ryan Meyerhoff; Robert Parks; Julia Cavanaugh Scull; Lu Wang; Nathan A Vandergrift; Joy Pickeral; Justin Pollara; Garnett Kelsoe; S Munir Alam; Guido Ferrari; David C Montefiori; Gerald Voss; Hua-Xin Liao; Georgia D Tomaras; Barton F Haynes
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

4.  Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Curtis R Chong; Vivian J Park; Bevin Cohen; Michael A Postow; Jedd D Wolchok; Mini Kamboj
Journal:  Clin Infect Dis       Date:  2020-01-02       Impact factor: 9.079

5.  Seasonal variability in the activity of common chronic liver diseases.

Authors:  Daniel Iluz-Freundlich; Julia Uhanova; Gerald Y Minuk
Journal:  Can Liver J       Date:  2019-12-10

Review 6.  Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.

Authors:  Sanket Shah; Debashish Danda; Chengappa Kavadichanda; Saibal Das; M B Adarsh; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2020-07-14       Impact factor: 2.631

Review 7.  Arginine as a synergistic virucidal agent.

Authors:  Satoshi Ohtake; Tsutomu Arakawa; A Hajime Koyama
Journal:  Molecules       Date:  2010-03-08       Impact factor: 4.411

8.  Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis Cohort.

Authors:  Fatima Kudaeva; Mark Speechley; Neil Klar; Orit Schieir; Susan J Bartlett; Louis Bessette; Gilles Boire; Glen Hazlewood; Carol A Hitchon; Edward Keystone; Diane Tin; Carter Thorne; Vivian P Bykerk; Janet E Pope
Journal:  ACR Open Rheumatol       Date:  2019-03-15

9.  Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.

Authors:  Narjes Saheb Sharif-Askari; Fatemeh Saheb Sharif-Askari; Samrein B M Ahmed; Suad Hannawi; Rifat Hamoudi; Qutayba Hamid; Rabih Halwani
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

Review 10.  Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk.

Authors:  Adrianna P Kępińska; Conrad O Iyegbe; Anthony C Vernon; Robert Yolken; Robin M Murray; Thomas A Pollak
Journal:  Front Psychiatry       Date:  2020-02-26       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.